Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up
Authors
Keywords
Viral load, AIDS, HIV, Adverse events, Antiretroviral therapy, Reverse transcriptase inhibitors, Drug therapy, Systematic reviews
Journal
PLoS One
Volume 9, Issue 5, Pages e97482
Publisher
Public Library of Science (PLoS)
Online
2014-05-16
DOI
10.1371/journal.pone.0097482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV
- (2013) James Jansson et al. AIDS
- Dolutegravir in antiretroviral-naive adults with HIV-1
- (2013) Hans-Jürgen Stellbrink et al. AIDS
- Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis
- (2013) Peter Messiaen et al. PLoS One
- Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials*
- (2012) C Stephan et al. HIV MEDICINE
- Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection
- (2012) Eduardo Gotuzzo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients
- (2012) Calvin J. Cohen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral Treatment of Adult HIV Infection
- (2012) Melanie A. Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
- (2012) Thomas B. Campbell et al. PLOS MEDICINE
- Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials
- (2011) J. A. Perez-Molina et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety and Efficacy of a 36-Week Induction Regimen of Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir in HIV-Infected Patients
- (2010) Kathleen E. Squires et al. HIV CLINICAL TRIALS
- Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study
- (2010) Frank A Post et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A comparison of the FDA TLOVR and FDA Snapshot algorithms based on studies evaluating once-daily vs. twice daily lopinavir/ritonavir (LPV/r) regimens
- (2010) R Qaqish et al. Journal of the International AIDS Society
- Efficacy and tolerability of initial antiretroviral therapy: a systematic review
- (2009) Andrew Carr et al. AIDS
- Virological Response to Initial Antiretroviral Regimens Containing Abacavir or Tenofovir
- (2009) Loveleen Bansi et al. JOURNAL OF INFECTIOUS DISEASES
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
- (2009) Paul E. Sax et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More